tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ONCT Stock Latest News

Oncternal Therapeutics price target lowered to $28 from $30 at H.C. Wainwright
The FlyOncternal Therapeutics price target lowered to $28 from $30 at H.C. Wainwright
3d ago
ONCT
Oncternal Participating in Virtual Fireside Chat with Key Opinion Leader on Treatment Landscape & New Treatment Options for Prostate Cancer
PremiumPress Releases
Oncternal Participating in Virtual Fireside Chat with Key Opinion Leader on Treatment Landscape & New Treatment Options for Prostate Cancer
1M ago
ONCT
Oncternal Therapeutics files $250M mixed securities shelf
PremiumThe Fly
Oncternal Therapeutics files $250M mixed securities shelf
1M ago
ONCT
Oncternal Therapeutics reports Q4 EPS ($3.11), consensus (3.07)
PremiumThe Fly
Oncternal Therapeutics reports Q4 EPS ($3.11), consensus (3.07)
1M ago
ONCT
Oncternal Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2023 Financial Results
PremiumPress Releases
Oncternal Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2023 Financial Results
1M ago
ONCT
Oncternal Therapeutics (ONCT) Q4 Earnings Cheat Sheet
PremiumPre-EarningsOncternal Therapeutics (ONCT) Q4 Earnings Cheat Sheet
1M ago
ONCT
Oncternal Therapeutics to Participate in Oppenheimer 34th Annual Healthcare Life Sciences Conference
PremiumPress Releases
Oncternal Therapeutics to Participate in Oppenheimer 34th Annual Healthcare Life Sciences Conference
2M ago
ONCT
Oncternal Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress Releases
Oncternal Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
3M ago
ONCT
Oncternal Therapeutics reports inducement award under Nasdaq listing rule
PremiumThe Fly
Oncternal Therapeutics reports inducement award under Nasdaq listing rule
3M ago
ONCT
Oncternal Therapeutics target adjusted to $30 from $2 at H.C. Wainwright
PremiumThe Fly
Oncternal Therapeutics target adjusted to $30 from $2 at H.C. Wainwright
3M ago
ONCT
Oncternal enrolls patients into third dosing cohort of Phase 1/2 trial
PremiumThe Fly
Oncternal enrolls patients into third dosing cohort of Phase 1/2 trial
3M ago
ONCT
Oncternal Therapeutics Enrolls Patients into the Third Dosing Cohort of its Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer
PremiumPress Releases
Oncternal Therapeutics Enrolls Patients into the Third Dosing Cohort of its Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer
3M ago
ONCT
Oncternal Therapeutics trading halted, news pending
PremiumThe FlyOncternal Therapeutics trading halted, news pending
3M ago
ONCT
Oncternal Therapeutics Announces Reverse Stock Split
PremiumPress Releases
Oncternal Therapeutics Announces Reverse Stock Split
3M ago
ONCT
Oncternal Therapeutics to effect 1-for-20 reverse stock split
PremiumThe Fly
Oncternal Therapeutics to effect 1-for-20 reverse stock split
3M ago
ONCT
Oncternal Therapeutics reports inducement award under Nasdaq listing rule
PremiumThe Fly
Oncternal Therapeutics reports inducement award under Nasdaq listing rule
4M ago
ONCT
Oncternal Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress Releases
Oncternal Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
4M ago
ONCT
Oncternal Therapeutics Updates the Status of its Phase 1/2 Study of ONCT-808, a ROR1-Targeting Autologous CAR T, in Patients with Relapsed or Refractory Aggressive B-cell Lymphoma
PremiumPress Releases
Oncternal Therapeutics Updates the Status of its Phase 1/2 Study of ONCT-808, a ROR1-Targeting Autologous CAR T, in Patients with Relapsed or Refractory Aggressive B-cell Lymphoma
4M ago
ONCT
Oncternal Therapeutics provides update on Phase 1/2 study of lymphoma candidate
PremiumThe Fly
Oncternal Therapeutics provides update on Phase 1/2 study of lymphoma candidate
4M ago
ONCT
Oncternal Therapeutics upgraded to Buy from Hold at Brookline
PremiumThe FlyOncternal Therapeutics upgraded to Buy from Hold at Brookline
5M ago
ONCT
Oncternal Therapeutics Provides Business Update and Announces Third Quarter 2023 Financial Results
PremiumPress Releases
Oncternal Therapeutics Provides Business Update and Announces Third Quarter 2023 Financial Results
5M ago
ONCT
ONCT Earnings this Week: How Will it Perform?
PremiumPre-Earnings
ONCT Earnings this Week: How Will it Perform?
5M ago
ONCT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >